Sign in
4

Changes in Ownership

Avalo Therapeutics, Inc. Filed Acc 0002047607-26-000008

Chief Strategy Officer sold 2,655 shares at $19.59 ($52,012)

From the SEC's structured data for this filing

Trades in this filing

Riley Jennifer · Chief Strategy Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-08-11 Sale : show line 1 in the form −2,655 $19.59 $52,012 37,041 D
Open-market sales · 2,655 sh · avg $19.59 · $52,012
Loading xslF345X06/form4-08122026_040809.xml…